Navigation Links
Rensselaer researcher wins $1.4 million NIH grant to enable faster cancer treatment planning
Date:5/26/2010

Troy, N.Y. Rensselaer Polytechnic Institute Professor Richard Radke is leading a new $1.4 million study to develop novel computer automation techniques that could reduce the prep time of a promising cancer-treatment technology from several hours to a few minutes.

This promising method, called intensity-modulated radiation therapy (IMRT), is extremely effective for treating cancer. Pioneered by the Memorial Sloan-Kettering Cancer Center in 1996, IMRT delivers non-uniform doses of radiation from different angles to a tumor site, and enables a high dose to be delivered to a tumor while at the same time delivering a low dose to nearby healthy tissue.

Creating an acceptable IMRT plan, however, requires several hours of preparatory trial-and-error adjustments and optimizations to ensure the radiation administered to the tumor does not impact surrounding healthy tissue. Radke is working to simplify and automate this optimization process, which currently requires an expert human technician to manually adjust many parameters in order to best accomplish the physician's goals and specifications.

Collaborating with colleagues at the Memorial Sloan-Kettering Cancer Center, Radke and his graduate students had previously created and successfully demonstrated effective algorithms for automating the optimization of IMRT for prostate cancer, trimming the computational prep time down to five minutes using a standard desktop computer. In this new four-year, $1.4 million study, funded by the U.S. National Institutes of Health National Cancer Institute, Radke will adapt his approach, called Reduced-Order Constrained Optimization (ROCO), to IMRT treatment of tumors in the lung, head, and neck.

"For IMRT and similar new technologies to reach their full potential as life-saving tools for treating cancer, it is critical to reduce planning times down to a matter of minutes. This is the challenge we are going to tackle in our new NIH-funded study," said Radke, associate professor in the Department of Electrical, Computer, and Systems Engineering at Rensselaer. "In the longer term, we believe our proposed approach will provide deeper insight into the science of radiation dose optimization, and reduce both the subjectivity and trial-and-error aspect of radiation therapy treatment plan selection."

The new study is titled "Reduced-Order Constrained Optimization for Rapid IMRT and VMAT Treatment Planning." Extending the techniques Radke's team developed for the prostate to treat tumors in the lung, head, or neck presents a challenge, since in the latter sites many healthy, radiation-sensitive tissues are typically clustered near tumors. A further challenge is adapting ROCO to the even more advanced technology of Volumetric-Modulated Arc Therapy (VMAT), in which radiation is continuously delivered to the patient in a smooth arc instead of at a few discrete positions.

As part of the new study, Radke will work with researchers at Memorial Sloan-Kettering Cancer Center to integrate the ROCO tools into the center's clinical treatment planning system, to refine and test the optimization improvements in an experimental, real-world setting.


'/>"/>

Contact: Michael Mullaney
mullam@rpi.edu
518-276-6161
Rensselaer Polytechnic Institute
Source:Eurekalert

Related medicine news :

1. Researcher to track spread of disease, malware and power outages
2. UCSF Researchers Identify Regulator of Human Sperm Cells
3. Women should be allowed to eat, drink during labor: Queens University researcher
4. Researchers find broad spectrum antiviral that fights multitude of viruses
5. University of Alberta researchers develop drug interface to save lives
6. Caregivers of ICU patients are collateral damage of critical illness, say Pitt researchers
7. Researchers fight world hunger by mapping the soybean genome
8. HIV researchers solve key puzzle after 20 years of trying
9. UC Davis researchers identify brain protein for synapse development
10. UCLA cancer researchers perform complete genomic sequencing of brain cancer cell line
11. Researchers find new way to study how enzymes repair DNA damage
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/13/2017)... ... October 13, 2017 , ... ProVest Insurance Group, a family ... and Raleigh regions, is organizing an extended charity drive to benefit the family ... abnormality. , After struggling since birth with several health challenges, T.J. was later ...
(Date:10/13/2017)... ... October 13, 2017 , ... The ... to promote standards of excellence for the field of eating disorders, announces the ... – 25, 2018 in Orlando, Florida at the Omni Resort at ChampionsGate. ...
(Date:10/13/2017)... LUIS OBISPO, Calif. (PRWEB) , ... October 13, 2017 , ... ... Alzheimer’s or dementia. However, many long-term care insurance companies have a waiver for care ... is the 90-day elimination period, when the family pays for care, is often waived, ...
(Date:10/13/2017)... ... October 13, 2017 , ... Talented host, actor Rob Lowe, ... in a new episode of "Success Files," which is an award-winning educational program ... investigates each subject in-depth with passion and integrity. , Sciatica occurs when the ...
(Date:10/12/2017)... ... October 12, 2017 , ... CitiDent and San ... using cutting-edge Oventus O2Vent technology. As many as 18 million Americans are ... cessation in breathing. Oral appliances can offer significant relief to about 75 percent ...
Breaking Medicine News(10 mins):
(Date:9/25/2017)... , Sept. 25, 2017  EpiVax, Inc., a ... design, and immune-engineering today announced the launch of ... development of personalized therapeutic cancer vaccines. EpiVax has ... exclusive access to enabling technologies to the new ... will lead EpiVax Oncology as Chief Executive Officer. ...
(Date:9/22/2017)... ROCKVILLE, Md. , Sept. 22, 2017  As ... by Republican Senators Bill Cassidy (R-LA) and ... Kalorama Information notes that the medical device industry is ... the medical device tax, the 2.3% excise tax on ... Act.  But they also want covered patients, increased visits ...
(Date:9/19/2017)... Sept. 19, 2017 HistoSonics, Inc., a venture-backed medical device company developing a non-invasive, ... tissues, announced three leadership team developments today:   ... ... ... Veteran medical device executive Josh Stopek , PhD, ...
Breaking Medicine Technology: